The distribution of Moderna’s COVID-19 vaccine began over the weekend, just days after the Food and Drug Administration granted emergency use authorization. Healthcare workers and residents of senior facilities are first in line for the current batch of doses. (CBS News)
Workers in hospitals and nursing homes continue to endure personal protective equipment shortages. President-Elect Joe Biden is being urged to consider using the Defense Production Act to increase manufacturing of PPE when he takes office. (The New York Times)
The Food and Drug Administration declined to approve Novartis’ cholesterol drug inclisiran, marketed under the brand name Leqvio. Novartis indicated it would meet with its manufacturing partner and the FDA to discuss next steps. (Reuters).
In response to a new strain of COVID-19 that has emerged in England, several nations – including France, Germany and Canada, but not the United States – have closed their borders to travelers from the U.K. Health experts note that while the COVID variant appears to be around 70% more contagious than other strains, there are no indications that it is more deadly. (NPR)
The Food and Drug Administration approved Myovant Science’s Orgovyx, a once-a-day pill for advanced prostate cancer. In its decision, the FDA noted the benefits of a treatment option that does not require in-person visits. (Endpoints News)